Last updated on November 2017

To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.


Brief description of study

To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.

Detailed Study Description

This study will see if an investigational drug called NYX-2925 can reduce the nerve pain in the legs and feet associated with painful diabetic peripheral neuropathy.

Clinical Study Identifier: TX14162

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jennifer Cavin

NeuroStudies.net, LLC
Decatur, GA USA
  Connect »